参考文献/References:
[1] DOLEEB Z,MCCOY L G,DADA J,et al.Underrecognition of dysmenorrhea is an iatrogenic harm[J].AMA J Ethics,2022,24(8):E740-E747.
[2] LAI S,JIN Q,WANG D,et al.Effects of menstrual disorders and dysmenorrhea on cardiovascular disease:A mendelian randomization study[J].Front Endocrinol(Lausanne),2024,15:1302312.
[3] 刘玲慧,袁滢,潘玉,等.穴位埋线联合丹莪妇康煎膏治疗子宫内膜异位症痛经疗效及对患者血清CA125的影响[J].陕西中医,2025,46(1):122-125.
[4] 孙青凤,杨君君,任亚娟,等.暖宫消癥散结汤联合中药灌肠治疗子宫腺肌症疗效及对患者痛经症状积分、子宫内膜厚度和血清CA125水平的影响[J].陕西中医,2023,44(6):742-745.
[5] WANG L,YAN Y,QIU H,et al.Prevalence and Risk factors of primary dysmenorrhea in students:A meta-analysis[J].Value Health,2022,25(10):1678-1684.
[6] 钟苗,张柳,刘浩然,等.Wa LIDD量表对女大学生痛经的诊断效能及痛经影响因素分析[J].保健医学研究与实践,2024,21(8):104-110.
[7] MARDON A K,WHITAKER L,FAROOQI T,et al.Investigational drugs for the treatment of dysmenorrhea[J].Expert Opin Investig Drugs,2024,33(4):347-357.
[8] CORTES H,HERNANDEZ-PARRA H,BERNAL-CHAVEZ S A,et al.Current status of the therapeutic approach for dysmenorrhea[J].Cell Mol Biol(Noisy-le-grand),2023,69(3):52-63.
[9] 刘今,刘君,王雪松,等.不同剂量麦粒灸对寒湿凝滞型原发性痛经患者子宫动脉血流影响的比较研究[J].针刺研究,2024,49(7):760-768.
[10] 龙金桃,郑文兰,黄李梅.加味温脐化湿汤治疗寒湿凝滞型原发性痛经疗效及对血液流变学的影响[J].现代中西医结合杂志,2022,31(2):198-202.
[11] 乐杰.妇产科学[M].6版.北京:人民卫生出版社,2004:347.
[12] 国家中医药管理局.中医病证诊断疗效标准[S].北京:中国医药科技出版社,2012:234.
[13] BURNETT M,LEMYRE M.No.345-primary dysmenorrhea consensus guideline[J].J Obstet Gynaecol Can,2017,39(7):585-595.
[14] BARBOSA-SILVA J,AVILA M A,DE OLIVEIRA R F,et al.Prevalence,pain intensity and symptoms associated with primary dysmenorrhea:A cross-sectional study [J].BMC Womens Health,2024,24(1):92.
[15] KAROUT S,SOUBRA L,RAHME D,et al.Prevalence,risk factors,and management practices of primary dysmenorrhea among young females [J].BMC Womens Health,2021,21(1):392.
[16] 李雨宸,潘子倩,肖梦雪,等.非甾体类抗炎药致小肠损伤及药物防治的研究进展[J].中国药科大学学报,2023,54(2):150-158.
[17] 盛锦义,姜景平,汪福昌.老年消化道出血临床特征及与HP感染、非甾体抗炎药物使用的关系[J].中国老年学杂志,2022,42(24):5978-5980.
[18] 《中医病证诊断疗效标准?原发性痛经》项目组,杜惠兰,梁潇,等.中医病证诊断疗效标准?原发性痛经(修订)[J].中华中医药杂志,2024,39(4):1884-1887.
[19] LIU W,WANG C C,LEE K H,et al.Research methodology in acupuncture and moxibustion for managing primary dysmenorrhea:A scoping review [J].Complement Ther Med,2022,71:102874.
[20] SUN C Y,XIONG Z Y,SUN C Y,et al.Placebo response of sham acupuncture in patients with primary dysmenorrhea:A meta-analysis [J].J Integr Med,2023,21(5):455-463.
[21] YANG X,TIAN Y,LIU J,et al.Peony pollen protects against primary dysmenorrhea in mice by inhibiting inflammatory response and regulating the COX2/PGE2 Pathway [J].Int J Mol Sci,2023,24(24):17245.
[22] 王琳,贺鹤.血府逐瘀颗粒治疗气滞血瘀证原发性痛经的疗效及对患者血清PAF和β-内啡肽的影响[J].海南医学,2022,33(3):338-341.
[23] ITANI R,SOUBRA L,KAROUT S,et al.Primary dysmenorrhea:Pathophysiology,diagnosis,and treatment updates [J].Korean J Fam Med,2022,43(2):101-108.
[24] 毕俊华,杨燕,颛洪娟,等.基于分子对接技术探讨巴戟天改善子宫内膜容受性的机制[J].中国性科学,2024,33(8):126-131.
[25] 雷蕾,李小阳,刘骏,等.化学功效组学:中药现代研究的新方向——以止血药和活血化瘀药核心成分群研究为例[J].中国中药杂志,2022,47(24):6803-6809.
相似文献/References:
[1]周宇博,吴红斌△.壮医药线点灸对寒湿凝滞型痛经大鼠血栓素B2及血液流变学的影响*[J].陕西中医,2019,(10):1330.
ZHOU Yubo,WU Hongbin..The effect of mtmz therapy on model of cold damp stagnation type dysmenorrhea rat thromboxane B2 and blood rheology[J].,2019,(5):1330.
[2]王晓莉,刘慧杰,于增瑞,等.柴附青金汤治疗原发性痛经气滞血瘀证疗效研究*[J].陕西中医,2020,(12):1704.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.006]
WANG Xiaoli,LIU Huijie,YU Zengrui,et al.Efficacy of Chaifu Qingjin decoction in the treatment of primary dysmenorrhea with syndrome of Qizhi Xueyu[J].,2020,(5):1704.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.006]
[3]杜翠忠,张晓静,冯亚宏,等.基于NLRP3/NF-κB/COX-2信号通路探讨痛经胶囊对原发性痛经大鼠的影响[J].陕西中医,2025,46(1):25.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.005]
DU Cuizhong,ZHANG Xiaojing,FENG Yahong,et al.Based on the NLRP3/NF-κB/COX-2 signal pathway to explore Tongjing capsule pairs effect of primary menstrual pain on rats[J].,2025,46(5):25.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.005]